Does medicare cover wegovy for heart disease?

Does Medicare cover Wegovy (semaglutide) for heart disease?

Medicare coverage for Wegovy depends on the specific diagnosis and the plan’s rules. Wegovy is approved for weight management (including reducing cardiovascular risk in adults with obesity/overweight who have established cardiovascular disease), but Medicare typically does not cover anti-obesity drugs under the same rules it uses for many other conditions. Coverage is often limited because these medications are frequently treated as “weight loss” drugs rather than standard treatment for heart disease.

That means: even if Wegovy is used to help reduce cardiovascular risk, Medicare often will not cover it unless the plan covers it under its prescription drug benefit and the drug is covered for the patient’s specific indication.

What diagnosis matters: obesity/overweight with cardiovascular disease vs “heart disease treatment”?

People often search this question when they want treatment for heart disease directly. Medicare coverage is more likely to hinge on whether the prescription is tied to Wegovy’s labeled use for weight management (and cardiovascular risk reduction) versus coverage rules for heart-failure or other cardiac indications. Coverage determinations generally follow the drug benefit rules and the prior-authorization/medical-necessity criteria set by the Part D plan.

Will Medicare cover Wegovy under Part D?

Many people who want Wegovy use Medicare Part D (prescription drug coverage), where coverage is plan-specific. Even if a plan covers Wegovy, it may require:
- prior authorization,
- documentation of body mass index (BMI) and related criteria,
- confirmation of qualifying cardiovascular risk factors for the intended use,
- and step therapy (trying other covered options first), depending on the plan.

If a Part D plan excludes anti-obesity medications, Wegovy may be denied regardless of medical need.

What if a doctor prescribes it for cardiovascular risk reduction—will it still be denied?

A prescription for “heart disease risk reduction” does not guarantee coverage. If the Medicare Part D plan treats Wegovy as an anti-obesity medication and excludes or restricts it, the claim can still be denied even when the clinician documents cardiovascular benefit.

How to check coverage quickly (before asking for prior authorization)

To find out whether your plan covers Wegovy, check:
- your specific Part D formulary (drug list),
- whether Wegovy is listed and the tier it falls under,
- whether prior authorization is required,
- and whether the plan has an exclusion for anti-obesity medications.

If you tell me your Part D plan name (or insurer) and whether you have Medicare Advantage or Part D, I can outline what to look for in that plan’s coverage rules.

Alternatives Medicare may cover

If Wegovy is denied, clinicians sometimes consider other covered weight-management or diabetes-related medications depending on the patient’s conditions. Coverage will still depend on your plan’s formulary and prior-authorization criteria.

Sources

I don’t have the specific Medicare/Wegovy coverage rules and your plan’s formulary details in the provided information, so I can’t cite exact policy language here. If you share your plan type (Original Medicare + Part D vs Medicare Advantage) and plan name, I can help you interpret what coverage usually depends on.